What Life Sciences Companies Need to Know in 2025
By EsqSocial Corporation 29/04/25
Key Insights for Pharma Manufacturers Regarding the AKS - In a series of recent legal challenges initiated by the pharmaceutical industry against the US Department of Health and Human Services Office of the Inspector General (OIG), manufacturers have contested the OIG’s long-standing interpretation of the Anti-Kickback Statute (AKS)....
By: ArentFox Schiff